Performance analysis of Capricor Therapeutics (CAPR)
Annual Return
Over the past 3 years, CAPR has had an average annual return of +82.11%, outperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CAPR has had an average annual return of +47.56%, outperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, CAPR has had an average annual return of -1.65%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Feb 13, 2007, CAPR has had an average annual return of -13.50%, underperforming the benchmark SPY, which returned +10.99% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.15% | +108.79% | +181.65% | +26.74% | +32.31% | -14.47% | +171.43% | -69.23% | -74.07% | -40.61% | -13.47% | -18.01% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| +15.37% | +29.86% | -90.90% | -11.29% | -48.76% | +42.35% | -84.55% | +511.11% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -24.18% | +27.78% | +8.86% | +10.36% | -10.72% | -8.71% | -5.15% | ||||||
| 2025 | +8.79% | +2.40% | -38.30% | +33.65% | -21.99% | +0.45% | -17.65% | -23.08% | +14.29% | -9.38% | -17.93% | +438.66% | +108.79% |
| 2024 | -17.43% | +3.33% | +62.37% | -22.52% | +7.69% | -15.87% | -15.09% | +13.33% | +231.37% | +32.25% | -5.59% | -27.25% | +181.65% |
| 2023 | +9.30% | +7.45% | -6.93% | -8.51% | +17.44% | +4.95% | -7.55% | +46.94% | -47.22% | -17.11% | +4.76% | +65.15% | +26.74% |
| 2022 | +21.54% | +13.92% | -15.56% | -7.89% | +15.71% | -3.70% | +30.77% | +26.47% | +3.10% | -6.77% | -20.16% | -13.13% | +32.31% |
| 2021 | +92.11% | -6.85% | -23.53% | -0.96% | -18.45% | +35.71% | -14.91% | +14.43% | -19.82% | -6.74% | -9.64% | -13.33% | -14.47% |
| 2020 | +21.43% | -23.53% | +3.85% | +477.78% | -33.97% | -0.97% | +73.53% | -24.29% | -12.69% | -26.50% | +8.14% | -18.28% | +171.43% |
| 2019 | +24.18% | -13.27% | +6.12% | +2.88% | -35.51% | +7.25% | +32.43% | -45.92% | +54.72% | -30.49% | -40.35% | -17.65% | -69.23% |
| 2018 | +26.50% | -9.01% | -25.25% | +1.66% | -3.58% | +0.68% | -12.75% | +3.46% | -13.38% | -11.16% | -17.39% | -46.78% | -74.07% |
| 2017 | -8.29% | +18.82% | +16.61% | -7.72% | -73.88% | +1.66% | +28.26% | -3.81% | +196.48% | -18.13% | -24.14% | -16.03% | -40.61% |
Drawdown analysis of Capricor Therapeutics (CAPR)
The maximum drawdown for the CAPR was -99.97%, occurring on Mar 9, 2020. This drawdown has not yet recovered.
The current CAPR drawdown is -99.16%.
Since Feb 13, 2007 CAPR has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 2 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Oct 24, 2007 | 3113 | Mar 9, 2020 | Ongoing | Ongoing | Ongoing |
| -56.27% | Feb 14, 2007 | 113 | Jul 27, 2007 | 36 | Sep 18, 2007 | 149 |
| -2.33% | Sep 25, 2007 | 2 | Sep 27, 2007 | 6 | Oct 5, 2007 | 8 |
| -2.22% | Oct 5, 2007 | 4 | Oct 11, 2007 | 9 | Oct 24, 2007 | 13 |